<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02413658</url>
  </required_header>
  <id_info>
    <org_study_id>1CSC2015</org_study_id>
    <nct_id>NCT02413658</nct_id>
  </id_info>
  <brief_title>Phenytoin in the Healing of Clean Surgical Wounds</brief_title>
  <official_title>Phenytoin in the Healing of Clean Surgical Wounds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Surgical Center, Cambodia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Surgical Center, Cambodia</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the potential healing properties of phenytoin.

      The investigators will use the donor site of a split skin thickness graft (SSTG) to model a
      basic wound in a randomized controlled trial of topical phenytoin against current best
      clinical practice. The investigators aim to demonstrate a dose dependent effect. The
      investigators hypothesis, based on previous clinical experience at our center and on current
      available literature, that phenytoin will reduce wound healing time.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage rate of re-epithelialization</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 20 days</time_frame>
    <description>Pictures taken of wound site every other day will be analysed using imaging software for size of wound. Percentage rate will be calculated from this.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Appearance of infection</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 20 days</time_frame>
    <description>Pictures taken of wound site every other day will be analysed using imaging software and the Southampton wound grading scale</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Wound</condition>
  <condition>Re-Epithelialization</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dressings of best current clinical practice, sugar solution.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phenytoin 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dressings using phenytoin solution 20mg/ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phenytoin 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dressings using phenytoin solution 40mg/ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenytoin</intervention_name>
    <description>Topical use of phenytoin solution on dressings of split thickness skin graft sites.</description>
    <arm_group_label>Phenytoin 1</arm_group_label>
    <arm_group_label>Phenytoin 2</arm_group_label>
    <other_name>Dilantin, Dilantin-125</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sugar solution</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing split thickness skin graft during trial time period at Children's Surgical
             Centre

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jim Gollogly</last_name>
    <phone>+85512979214</phone>
    <email>jim@csc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Surgical Centre</name>
      <address>
        <city>Phnom Penh</city>
        <country>Cambodia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jim Gollogly</last_name>
      <phone>+85512979124</phone>
      <email>jim@csc.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Cambodia</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2015</study_first_submitted>
  <study_first_submitted_qc>April 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2015</study_first_posted>
  <last_update_submitted>April 9, 2015</last_update_submitted>
  <last_update_submitted_qc>April 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Phenytoin</keyword>
  <keyword>Skin graft donor site</keyword>
  <keyword>Clean surgical site</keyword>
  <keyword>Wound model</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Phenytoin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

